Biden administration panned for sidestepping advisory panel to allow fourth COVID-19 shot

Published



The Biden administration‘s approval of a fourth mRNA COVID-19 shot for those 50 and older has raised eyebrows in political and medical circles.

The Food and Drug Administration authorized a second booster shot of the Pfizer-BioNTech and Moderna vaccines for older adults and people as young as 12 with certain immune deficiencies but did so without convening a meeting of its panel of vaccine experts first, a move that angered healthcare experts skeptical of a fourth shot’s utility.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.